Results from our present meta-analysis were in line with the above results and revealed a significant increase in reversal rate from infection with G-CSF or GM-CSF therapy verse placebo (RR = 1.34, 95% CI: 1.11 to 1.62, P = 0.002). This evidence concerns the gene CSF3 and infection.